Coronex
Coronex is a collaboration of Scottish and UK based biotechnology industry partners working with NHS Greater Glasgow and Clyde clinical and biorepository teams on the development of highly optimised lateral flow tests. Whilst primary focus has been on SARS-CoV-2, the same core technology has applications for other infectious agents, and may also be used for monitoring therapeutic antibodies used as drug treatments or in detecting auto-antibodies in autoimmune disorders.
Coronex is a 2020 spin-out company of NHS Greater Glasgow and Clyde and InnoScot Health.
Chat